Sandra B. Hake studied Biology at RWTH Aachen University and completed her doctorate in Molecular Immunology at the Max Planck Institute in Freiburg. After postdoctoral work at Memorial Sloan Kettering Cancer Center and at Rockefeller University in the laboratory of C. David Allis, she established her own junior research group at LMU Munich, where she habilitated and received the LMU Habilitation Award. Since 2016, she has been W3 Professor at the Institute of Genetics at JLU Giessen and has served as Managing Director since 2019.
Her research focuses on the regulation of chromatin structure and gene expression by histone variants and post-translational histone modifications in human and murine systems, particularly in disease contexts. Her teaching covers genetics, epigenetics, and molecular biology in teacher training and Bachelor’s and Master’s programs.
She was President of the Gesellschaft für Genetik from 2024 to 2025.
